Register entry
ViiV Healthcare Company
- Registered sites
- 0
- Drug products
- 26
- Live patents
- 59
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
59Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| APRETUDE | CABOTEGRAVIR | Feb 2031 |
| APRETUDE | CABOTEGRAVIR | Sept 2031 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Jun 2027 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Feb 2031 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Sept 2031 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Nov 2031 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Apr 2032 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Jul 2038 |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | Oct 2040 |
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | Oct 2027 |
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | Apr 2028 |
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | Dec 2029 |
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | Jun 2030 |
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | Jan 2031 |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | Oct 2027 |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | Apr 2028 |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | Dec 2029 |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | Jun 2030 |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | Jan 2031 |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | Sept 2038 |
| RUKOBIA | FOSTEMSAVIR TROMETHAMINE | Nov 2027 |
| RUKOBIA | FOSTEMSAVIR TROMETHAMINE | Jul 2029 |
| TIVICAY | DOLUTEGRAVIR SODIUM | Oct 2027 |
| TIVICAY | DOLUTEGRAVIR SODIUM | Apr 2028 |
| TIVICAY | DOLUTEGRAVIR SODIUM | Dec 2029 |
| TIVICAY | DOLUTEGRAVIR SODIUM | Jun 2030 |
| TIVICAY PD | DOLUTEGRAVIR SODIUM | Oct 2027 |
| TIVICAY PD | DOLUTEGRAVIR SODIUM | Apr 2028 |
| TIVICAY PD | DOLUTEGRAVIR SODIUM | Dec 2029 |
| TIVICAY PD | DOLUTEGRAVIR SODIUM | Jun 2030 |
| TRIUMEQ | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Oct 2027 |
| TRIUMEQ | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Apr 2028 |
| TRIUMEQ | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Dec 2029 |
| TRIUMEQ | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Jun 2030 |
| TRIUMEQ PD | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Oct 2027 |
| TRIUMEQ PD | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Apr 2028 |
| TRIUMEQ PD | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Dec 2029 |
| TRIUMEQ PD | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | Jun 2030 |
| VOCABRIA | CABOTEGRAVIR SODIUM | Feb 2031 |
Catalogue
Marketed products
26Showing 26 of 26.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Apretude | Cabotegravir | KIT | NDA |
| Apretude | Cabotegravir | KIT | NDA |
| COMBIVIR | lamivudine and zidovudine | TABLET, FILM COATED | NDA |
| Cabenuva | cabotegravir and rilpivirine | KIT | NDA |
| Cabenuva | cabotegravir and rilpivirine | KIT | NDA |
| Cabenuva | cabotegravir and rilpivirine | KIT | NDA |
| Dovato | dolutegravir sodium and lamivudine | TABLET, FILM COATED | NDA |
| EPIVIR | lamivudine | TABLET, FILM COATED | NDA |
| EPIVIR | lamivudine | TABLET, FILM COATED | NDA |
| EPIVIR | lamivudine | SOLUTION | NDA |
| Juluca | dolutegravir sodium and rilpivirine hydrochloride | TABLET, FILM COATED | NDA |
| RETROVIR | zidovudine | CAPSULE | NDA |
| RETROVIR | zidovudine | SOLUTION | NDA |
| RETROVIR | zidovudine | INJECTION, SOLUTION | NDA |
| Rukobia | fostemsavir tromethamine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| SELZENTRY | maraviroc | TABLET, FILM COATED | NDA |
| SELZENTRY | maraviroc | TABLET, FILM COATED | NDA |
| SELZENTRY | maraviroc | KIT | NDA |
| Tivicay | dolutegravir sodium | TABLET, FILM COATED | NDA |
| Tivicay | dolutegravir sodium | TABLET, FILM COATED | NDA |
| Tivicay | dolutegravir sodium | TABLET, FILM COATED | NDA |
| Tivicay PD | dolutegravir sodium | TABLET, FOR SUSPENSION | NDA |
| Triumeq | abacavir sulfate, dolutegravir sodium, lamivudine | TABLET, FILM COATED | NDA |
| Triumeq PD | abacavir sulfate, dolutegravir sodium, lamivudine | KIT | NDA |
| Vocabria | cabotegravir sodium | TABLET, FILM COATED | NDA |
| ZIAGEN | abacavir sulfate | SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.